ARCHIMED-backed FIM Medical completed the acquisition of Vistec from 22 Ventures.

ARCHIMED-backed FIM Medical, which offers vision, hearing and respiratory care products, completed the acquisition of Vistec, a company specialized in vision screening devices, from 22 Ventures, a German investment firm. Financial terms were not disclosed. “ARCHIMED and FIM are exploring more acquisitions to expand products and geographical reach.” “We’ve substantially strengthened our leadership of European occupational healthcare with the purchase of Vistec,” Marie-Ange Derei, FIM Medical CEO.